cefuroxime has been researched along with Endophthalmitis in 97 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the impact of cefuroxime injection of intracameral prophylaxis antibiotic on after endophthalmitis operative wound following surgery of cataract, we conducted a meta-analysis." | 9.41 | Effect of cefuroxime intracameral injection antibiotic prophylactic on postoperative endophthalmitis wound post-cataract: A meta-analysis. ( Dong, H; Liu, Y; Wang, M, 2023) |
| "Intracameral injection of cefuroxime reduces the risk of postoperative infectious endophthalmitis following phacoemulsification cataract surgery." | 9.13 | [Will intracameral cefuroxime become the new standard in endophthalmitis prevention?]. ( Geldsetzer, K; Pleyer, U, 2008) |
| "Results of the landmark European Society of Cataract and Refractive Surgeons trial and additional prospective and retrospective studies support the use of intracameral cefuroxime in the prophylaxis of endophthalmitis following cataract surgery." | 8.89 | Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery. ( Keating, GM, 2013) |
| "Our purpose was to compare postoperative infectious endophthalmitis rates before and after the introduction of antibiotic prophylaxis via intracameral with cefuroxime (ATB-P IC) in a high-volume cataract surgery service." | 8.31 | The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high-volume cataract surgery center. ( de Sousa Casavechia, LN; Fernandes, AG; Fernandes, RAB; Meireles, AC; Schapira, E, 2023) |
| "The analysis aims to assess the cost-effectiveness of cefuroxime (Aprokam®) in the prophylaxis of postoperative endophthalmitis (POE) after cataract surgery compared with the absence of antibiotic prophylaxis from the National Health Fund perspective in Poland." | 7.96 | Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland. ( Dobrowolska, I; Golicki, D; Młyńczak, K; Niewada, M; Rękas, M, 2020) |
| "Intracameral cefuroxime as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery was introduced in 1996 at St Erik Eye Hospital." | 7.91 | Bacteriology and cefuroxime resistance in endophthalmitis following cataract surgery before and after the introduction of prophylactic intracameral cefuroxime: a retrospective single-centre study. ( Friling, E; Montan, P, 2019) |
| "Although topical antibiotics have been used as antimicrobial prophylaxis after ocular surgery, recent studies have determined that intracameral cefuroxime at the end of surgery significantly reduce the risk to suffer an infection and suggest that the use of topical antibiotics in the prophylaxis of infectious postoperative endophthalmitis (IPOE) is controversial." | 7.88 | Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops. ( Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J, 2018) |
| "To compare the efficacy of intracameral vancomycin, cefuroxime, and moxifloxacin on postoperative bacterial endophthalmitis rates." | 7.85 | Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin. ( Libre, PE; Mathews, S, 2017) |
| "To report a case series of post-phacoemulsification endophthalmitis despite antibiotic prophylaxis with an intracameral injection of a licensed cefuroxime formulation (Aprokam)." | 7.83 | Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime. ( Beral, L; David, T; Farès, S; Hage, R; Merle, H; Mesnard, C, 2016) |
| "The use of intracameral cefuroxime could significantly reduce the rate of postoperative endophthalmitis in a tertiary centre in Hong Kong." | 7.83 | Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong. ( Li, KK; Li, PS; Ng, AL; Tang, WW, 2016) |
| "Intracameral cefuroxime is recommended as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery." | 7.81 | Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis. ( Davey, K; Johnson, M; Pietri, G; Purslow, C; Suri, G, 2015) |
| "There is not strong evidence to support use of intracameral cefuroxime to reduce the rate of acute endophthalmitis after cataract surgery; however, the marginal benefit might justify its use." | 7.81 | Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. ( Das, S; Dhillon, V; Rath, S; Sahu, SK; Sharma, S, 2015) |
| "The incidence of postoperative endophthalmitis has reduced by approximately eightfold since the introduction of intracameral cefuroxime following cataract surgery at our hospital in 2007." | 7.81 | Impact of intracameral cefuroxime on the incidence of postoperative endophthalmitis following cataract surgery in Ireland. ( Murphy, CC; Rahman, N, 2015) |
| "Intracameral injection of cefuroxime reduces the rate of postoperative infectious endophthalmitis in cataract surgery significantly." | 7.80 | [Using intracameral cefuroxime reduces postoperative endophthalmitis rate: 5 years experience at the University Eye Hospital Tübingen]. ( Bartz-Schmidt, KU; Bramkamp, M; Mutlu, U; Röck, D; Röck, T; Thaler, S; Yörük, E, 2014) |
| "Intracameral cefuroxime reduced the incidence of endophthalmitis in cataract surgery and had a high clinical and economic impact on its prevention." | 7.79 | Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery. ( Andrés-Alba, Y; Arias-Puente, A; García-Sáenz, MC; Rodríguez-Caravaca, G; Villar-Del-Campo, MC, 2013) |
| "Intracameral cefuroxime injection at the end of cataract surgery was safe and significantly decreased the incidence of endophthalmitis." | 7.78 | Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. ( Adenis, JP; Barreau, G; Marin, B; Mounier, M; Robert, PY, 2012) |
| "The intracameral cefuroxime injection at the end of the cataract surgery is a means to consider to prevent endophthalmitis." | 7.76 | [Intracameral cefuroxime injections in prophylaxis of postoperative endophthalmitis after cataract surgery: implementation and results]. ( Colin, J; Gaudric, A; Gualino, V; Guillot, E; Korobelnik, JF; Massin, P; San, S; Tadayoni, R; Trout, H, 2010) |
| "Sodium cefuroxime is a second-generation cephalosporin widely used at 10mg/mL for endophthalmitis prophylaxis after cataract surgery." | 7.76 | Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis. ( Boillon, A; Burillon, C; Diouf, E; Falson, F; Leboucher, G; Padois, K; Pirot, F; Pivot, C; Senaux, E; Tall, L; Uhart, M, 2010) |
| "Intracameral cefuroxime proved to be effective in reducing the risk for acute-onset endophthalmitis after cataract surgery." | 7.76 | Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study. ( Arias-Puente, A; Bañuelos, JB; García-Sáenz, MC; Rodríguez-Caravaca, G, 2010) |
| "Cost per case of endophthalmitis prevented; theoretical maximal cost-effectiveness; efficacy threshold necessary to achieve cost-effective equivalence with intracameral cefuroxime; ratio indicating how many times more effective or less expensive alternative antibiotics would have to be to achieve cost-effective equivalence with intracameral cefuroxime." | 7.75 | Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. ( Naseri, A; Porco, TC; Sharifi, E, 2009) |
| "Intracameral cefuroxime works very well for reducing the incidence of postoperative endophthalmitis." | 7.75 | [Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience]. ( Arteta, M; De la Rosa, G; Díez, MR; Girón, C; Pascual, R, 2009) |
| "Intracameral cefuroxime was a safe alternative to subconjunctival cefuroxime and led to a lower rate of endophthalmitis." | 7.74 | Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. ( Allen, D; Hildreth, AJ; Morgan, SJ; Steel, DH; Yu-Wai-Man, P, 2008) |
| "Intracameral cefuroxime 1 mg appeared to effectively inhibit sensitive bacterial strains and was associated with a low frequency of postoperative endophthalmitis." | 7.71 | Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. ( Koranyi, G; Montan, PG; Rylander, M; Wejde, G, 2002) |
| "These data suggest that, in routine practice, the intracameral injection of cefuroxime at the conclusion of cataract surgery is associated with a lower risk of POE and is safe for patients with or without a perioperative capsular rupture." | 5.43 | Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture. ( Carriere, I; Daien, V; Daures, JP; Domerg, C; Gillies, MC; Lacombe, S; Nagot, N; Papinaud, L; Villain, M, 2016) |
| "To assess the impact of cefuroxime injection of intracameral prophylaxis antibiotic on after endophthalmitis operative wound following surgery of cataract, we conducted a meta-analysis." | 5.41 | Effect of cefuroxime intracameral injection antibiotic prophylactic on postoperative endophthalmitis wound post-cataract: A meta-analysis. ( Dong, H; Liu, Y; Wang, M, 2023) |
| "Postoperative endophthalmitis is an uncommon complication of cataract surgery with grave consequences." | 5.39 | Reduction in postoperative endophthalmitis with intracameral cefuroxime. ( Desai, SP; Jayamanne, DG; Myneni, J, 2013) |
| "Intracameral injection of cefuroxime reduces the risk of postoperative infectious endophthalmitis following phacoemulsification cataract surgery." | 5.13 | [Will intracameral cefuroxime become the new standard in endophthalmitis prevention?]. ( Geldsetzer, K; Pleyer, U, 2008) |
| "Intracameral cefuroxime administered at the time of surgery significantly reduced the risk for developing endophthalmitis after cataract surgery." | 5.12 | ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. ( Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV, 2006) |
| "This partially masked randomized placebo-controlled multinational clinical study was designed to evaluate prospectively the prophylactic effect of intracameral cefuroxime and/or perioperative topical levofloxacin on postoperative endophthalmitis after cataract surgery." | 5.12 | ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study. ( Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV; Wilhelmus, KR, 2006) |
| "Use of intracameral cefuroxime at the end of surgery reduced the occurrence of postoperative endophthalmitis." | 5.12 | Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. ( , 2007) |
| " The average weighted postoperative endophthalmitis incidence rates with intracameral cefuroxime, moxifloxacin and vancomycin were 0." | 4.98 | Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. ( Ambati, BK; Bardsley, T; Bondalapati, S; Bowen, RC; Evans, PR; Greene, T; Kliethermes, M; Lawyer, TW; Mamalis, CA; McFarland, M; Rudnisky, CJ; Shi, D; Snow, KB; Zhou, AX, 2018) |
| "Based on current evidence, the recommended measures for endophthalmitis prophylaxis are preoperative topical instillation of povidone-iodine and intracameral antibiotic injection at the end of cataract surgery." | 4.89 | Role of topical, subconjunctival, intracameral, and irrigative antibiotics in cataract surgery. ( Basu, S; Vazirani, J, 2013) |
| "Results of the landmark European Society of Cataract and Refractive Surgeons trial and additional prospective and retrospective studies support the use of intracameral cefuroxime in the prophylaxis of endophthalmitis following cataract surgery." | 4.89 | Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery. ( Keating, GM, 2013) |
| "Our purpose was to compare postoperative infectious endophthalmitis rates before and after the introduction of antibiotic prophylaxis via intracameral with cefuroxime (ATB-P IC) in a high-volume cataract surgery service." | 4.31 | The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high-volume cataract surgery center. ( de Sousa Casavechia, LN; Fernandes, AG; Fernandes, RAB; Meireles, AC; Schapira, E, 2023) |
| "Endophthalmitis cases with positive cultures were generally related to organism resistance in cefuroxime eyes but to sensitive organisms in moxifloxacin eyes." | 4.02 | Endophthalmitis Prophylaxis Failures in Patients Injected With Intracameral Antibiotic During Cataract Surgery. ( Carolan, JA; Herrinton, L; Liu, L; Shorstein, NH, 2021) |
| "Intracameral cefuroxime appears to be a safe and efficient choice for prophylaxis against endophthalmitis after PPV." | 4.02 | Safety of intracameral cefuroxime in pars plana vitrectomy. ( Kumaran, N; Laidlaw, DAH; Neffendorf, JE; Sandinha, T; Williamson, TH; Wong, RS, 2021) |
| "The analysis aims to assess the cost-effectiveness of cefuroxime (Aprokam®) in the prophylaxis of postoperative endophthalmitis (POE) after cataract surgery compared with the absence of antibiotic prophylaxis from the National Health Fund perspective in Poland." | 3.96 | Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland. ( Dobrowolska, I; Golicki, D; Młyńczak, K; Niewada, M; Rękas, M, 2020) |
| "Intracameral cefuroxime as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery was introduced in 1996 at St Erik Eye Hospital." | 3.91 | Bacteriology and cefuroxime resistance in endophthalmitis following cataract surgery before and after the introduction of prophylactic intracameral cefuroxime: a retrospective single-centre study. ( Friling, E; Montan, P, 2019) |
| "To create a model of the abatement profiles of the three most commonly employed endophthalmitis prophylaxis intracameral (IC) antibiotics-cefuroxime, vancomycin, and moxifloxacin-to enable comparison of their durations of efficacy against common endophthalmitis pathogens." | 3.91 | Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies. ( Arshinoff, SA; Felfeli, T; Modabber, M, 2019) |
| "Although topical antibiotics have been used as antimicrobial prophylaxis after ocular surgery, recent studies have determined that intracameral cefuroxime at the end of surgery significantly reduce the risk to suffer an infection and suggest that the use of topical antibiotics in the prophylaxis of infectious postoperative endophthalmitis (IPOE) is controversial." | 3.88 | Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops. ( Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J, 2018) |
| "To compare the efficacy of intracameral vancomycin, cefuroxime, and moxifloxacin on postoperative bacterial endophthalmitis rates." | 3.85 | Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin. ( Libre, PE; Mathews, S, 2017) |
| "The use of intracameral cefuroxime could significantly reduce the rate of postoperative endophthalmitis in a tertiary centre in Hong Kong." | 3.83 | Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong. ( Li, KK; Li, PS; Ng, AL; Tang, WW, 2016) |
| "Injecting intracameral cefuroxime has been found beneficial in reducing the risk of postoperative endophthalmitis but its use has been limited through a lack of approved marketing and of ready-to-use single-units as well as the problem of aseptic compounding." | 3.83 | Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method. ( Barthélémy, C; Décaudin, B; Feutry, F; Genay, S; Labalette, P; Lannoy, D; Odou, P; Simon, N, 2016) |
| "To report a case series of post-phacoemulsification endophthalmitis despite antibiotic prophylaxis with an intracameral injection of a licensed cefuroxime formulation (Aprokam)." | 3.83 | Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime. ( Beral, L; David, T; Farès, S; Hage, R; Merle, H; Mesnard, C, 2016) |
| "Intracameral cefuroxime is recommended as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery." | 3.81 | Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis. ( Davey, K; Johnson, M; Pietri, G; Purslow, C; Suri, G, 2015) |
| "There is not strong evidence to support use of intracameral cefuroxime to reduce the rate of acute endophthalmitis after cataract surgery; however, the marginal benefit might justify its use." | 3.81 | Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. ( Das, S; Dhillon, V; Rath, S; Sahu, SK; Sharma, S, 2015) |
| "The incidence of postoperative endophthalmitis has reduced by approximately eightfold since the introduction of intracameral cefuroxime following cataract surgery at our hospital in 2007." | 3.81 | Impact of intracameral cefuroxime on the incidence of postoperative endophthalmitis following cataract surgery in Ireland. ( Murphy, CC; Rahman, N, 2015) |
| "Intracameral injection of cefuroxime reduces the rate of postoperative infectious endophthalmitis in cataract surgery significantly." | 3.80 | [Using intracameral cefuroxime reduces postoperative endophthalmitis rate: 5 years experience at the University Eye Hospital Tübingen]. ( Bartz-Schmidt, KU; Bramkamp, M; Mutlu, U; Röck, D; Röck, T; Thaler, S; Yörük, E, 2014) |
| "To determine the use of intracameral cefuroxime at the end of cataract surgery since the beneficial results were first reported by the European Society of Cataract and Refractive Surgeons Endophthalmitis Study Group in 2006, 250 ophthalmic surgeons affiliated with both public and private hospitals and clinics across Europe were surveyed." | 3.80 | Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. ( Barry, P, 2014) |
| "Intracameral cefuroxime reduced the incidence of endophthalmitis in cataract surgery and had a high clinical and economic impact on its prevention." | 3.79 | Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery. ( Andrés-Alba, Y; Arias-Puente, A; García-Sáenz, MC; Rodríguez-Caravaca, G; Villar-Del-Campo, MC, 2013) |
| "Intracameral cefuroxime was found to lower the risk of endophthalmitis after cataract surgery." | 3.78 | Physiological and toxicological effects of cefuroxime on the albino rabbit retina. ( Loewenstein, A; Perlman, I; Shahar, J; Zemel, E, 2012) |
| "Intracameral cefuroxime injection at the end of cataract surgery was safe and significantly decreased the incidence of endophthalmitis." | 3.78 | Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. ( Adenis, JP; Barreau, G; Marin, B; Mounier, M; Robert, PY, 2012) |
| " In open eye surgery, an additional antibioprophylaxis is recommended: in cataract surgery, injection in the anterior chamber at the end of the procedure of 1mg of cefuroxime; in other open eye surgeries, only in case of risk factors for endophthalmitis, administration of 500 mg oral levofloxacin tablet 12 hours and two hours before surgery." | 3.77 | [Antibioprophylaxis in ocular surgery: AFSSAPS recommendations]. ( Cochereau, I; Hajjar, J; Korobelnik, JF; Robert, PY, 2011) |
| "The intracameral cefuroxime injection at the end of the cataract surgery is a means to consider to prevent endophthalmitis." | 3.76 | [Intracameral cefuroxime injections in prophylaxis of postoperative endophthalmitis after cataract surgery: implementation and results]. ( Colin, J; Gaudric, A; Gualino, V; Guillot, E; Korobelnik, JF; Massin, P; San, S; Tadayoni, R; Trout, H, 2010) |
| "Intracameral cefuroxime proved to be effective in reducing the risk for acute-onset endophthalmitis after cataract surgery." | 3.76 | Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study. ( Arias-Puente, A; Bañuelos, JB; García-Sáenz, MC; Rodríguez-Caravaca, G, 2010) |
| "Sodium cefuroxime is a second-generation cephalosporin widely used at 10mg/mL for endophthalmitis prophylaxis after cataract surgery." | 3.76 | Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis. ( Boillon, A; Burillon, C; Diouf, E; Falson, F; Leboucher, G; Padois, K; Pirot, F; Pivot, C; Senaux, E; Tall, L; Uhart, M, 2010) |
| "Intracameral cefuroxime works very well for reducing the incidence of postoperative endophthalmitis." | 3.75 | [Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience]. ( Arteta, M; De la Rosa, G; Díez, MR; Girón, C; Pascual, R, 2009) |
| "The European Society of Cataract & Refractive Surgeons Endophthalmitis Study published preliminary results in 2006 showing a near 5-fold decrease in the rates of postoperative endophthalmitis with the use of intracameral cefuroxime." | 3.75 | United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study. ( Angunawela, RI; Gore, DM; Little, BC, 2009) |
| "Cost per case of endophthalmitis prevented; theoretical maximal cost-effectiveness; efficacy threshold necessary to achieve cost-effective equivalence with intracameral cefuroxime; ratio indicating how many times more effective or less expensive alternative antibiotics would have to be to achieve cost-effective equivalence with intracameral cefuroxime." | 3.75 | Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. ( Naseri, A; Porco, TC; Sharifi, E, 2009) |
| "Intracameral cefuroxime was a safe alternative to subconjunctival cefuroxime and led to a lower rate of endophthalmitis." | 3.74 | Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. ( Allen, D; Hildreth, AJ; Morgan, SJ; Steel, DH; Yu-Wai-Man, P, 2008) |
| " Injection of subconjunctival cefuroxime can be very painful, especially after phacoemulsification under topical anesthesia." | 3.71 | Topical anesthesia for phacoemulsification and painless subconjunctival antibiotic injection. ( Dinakaran, S; Kayarkar, VV, 2001) |
| "Intracameral cefuroxime 1 mg appeared to effectively inhibit sensitive bacterial strains and was associated with a low frequency of postoperative endophthalmitis." | 3.71 | Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. ( Koranyi, G; Montan, PG; Rylander, M; Wejde, G, 2002) |
| "Intracameral cefuroxime 1 mg appears safe in terms of local toxicity." | 2.70 | Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. ( Montan, PG; Rylander, M; Setterquist, H; Wejde, G; Zetterström, C, 2002) |
| "Cefuroxime has some theoretical advantages over gentamicin in its antibacterial spectrum." | 2.67 | Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery. ( Jenkins, CD; McDonnell, PJ; Spalton, DJ, 1990) |
| "These data suggest that, in routine practice, the intracameral injection of cefuroxime at the conclusion of cataract surgery is associated with a lower risk of POE and is safe for patients with or without a perioperative capsular rupture." | 1.43 | Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture. ( Carriere, I; Daien, V; Daures, JP; Domerg, C; Gillies, MC; Lacombe, S; Nagot, N; Papinaud, L; Villain, M, 2016) |
| "Cefuroxime was the intracameral antibiotic used in 99% of treated cases." | 1.42 | Risk factors for endophthalmitis after cataract surgery: Predictors for causative organisms and visual outcomes. ( Friling, E; Lundström, M; Montan, P, 2015) |
| "Postoperative endophthalmitis is an uncommon complication of cataract surgery with grave consequences." | 1.39 | Reduction in postoperative endophthalmitis with intracameral cefuroxime. ( Desai, SP; Jayamanne, DG; Myneni, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.03) | 18.2507 |
| 2000's | 26 (26.80) | 29.6817 |
| 2010's | 54 (55.67) | 24.3611 |
| 2020's | 16 (16.49) | 2.80 |
| Authors | Studies |
|---|---|
| Melega, MV | 1 |
| Alves, M | 1 |
| Lira, RPC | 1 |
| Kato, A | 1 |
| Horita, N | 1 |
| Namkoong, H | 1 |
| Nomura, E | 1 |
| Masuhara, N | 1 |
| Kaneko, T | 1 |
| Mizuki, N | 1 |
| Takeuchi, M | 1 |
| Agarwal, A | 1 |
| Wang, M | 1 |
| Liu, Y | 1 |
| Dong, H | 1 |
| de Sousa Casavechia, LN | 1 |
| Meireles, AC | 1 |
| Schapira, E | 1 |
| Fernandes, RAB | 1 |
| Fernandes, AG | 1 |
| Arshinoff, SA | 1 |
| Felfeli, T | 1 |
| Modabber, M | 1 |
| Rathi, VM | 1 |
| Sharma, S | 2 |
| Das, T | 1 |
| Khanna, RC | 1 |
| Agarwal, D | 1 |
| Kumar, A | 1 |
| Rękas, M | 1 |
| Młyńczak, K | 1 |
| Dobrowolska, I | 1 |
| Niewada, M | 1 |
| Golicki, D | 1 |
| Neffendorf, JE | 1 |
| Kumaran, N | 1 |
| Sandinha, T | 1 |
| Wong, RS | 1 |
| Laidlaw, DAH | 1 |
| Williamson, TH | 1 |
| Ghazal, W | 1 |
| Saad, A | 1 |
| Courtin, R | 1 |
| Gatinel, D | 1 |
| Panthier, C | 1 |
| Shorstein, NH | 2 |
| Liu, L | 2 |
| Carolan, JA | 1 |
| Herrinton, L | 1 |
| Yang, Y | 1 |
| Sui, W | 1 |
| Duan, F | 1 |
| Li, Y | 1 |
| Zeng, J | 1 |
| Jiang, Z | 1 |
| Liu, M | 1 |
| Yuan, Z | 1 |
| Lin, X | 1 |
| Chen, KJ | 1 |
| Chong, YJ | 1 |
| Sun, MH | 1 |
| Chen, HC | 1 |
| Chen, YP | 1 |
| Wu, WC | 1 |
| Kang, EY | 1 |
| Lai, CC | 1 |
| Chang, DF | 1 |
| Porwal, AC | 1 |
| Patel, A | 1 |
| Mathew, BC | 1 |
| Jethani, JN | 1 |
| Olson, RJ | 1 |
| Ng, AL | 2 |
| Li, PS | 2 |
| Li, KK | 2 |
| Lim, LW | 3 |
| Tan, CS | 3 |
| Libre, PE | 1 |
| Mathews, S | 1 |
| Bowen, RC | 1 |
| Zhou, AX | 1 |
| Bondalapati, S | 1 |
| Lawyer, TW | 1 |
| Snow, KB | 1 |
| Evans, PR | 1 |
| Bardsley, T | 1 |
| McFarland, M | 1 |
| Kliethermes, M | 1 |
| Shi, D | 1 |
| Mamalis, CA | 1 |
| Greene, T | 1 |
| Rudnisky, CJ | 1 |
| Ambati, BK | 1 |
| Friling, E | 2 |
| Montan, P | 3 |
| Tuñí-Picado, J | 1 |
| Martínez-Palmer, A | 1 |
| Fernández-Sala, X | 1 |
| Barceló-Vidal, J | 1 |
| Castilla-Martí, M | 1 |
| Cartagena-Guardado, Y | 1 |
| Grau, S | 1 |
| Sül, S | 1 |
| Karalezli, A | 1 |
| Rodríguez-Caravaca, G | 3 |
| García-Sáenz, MC | 4 |
| Villar-Del-Campo, MC | 1 |
| Andrés-Alba, Y | 1 |
| Arias-Puente, A | 3 |
| Myneni, J | 1 |
| Desai, SP | 1 |
| Jayamanne, DG | 1 |
| Zhang, MG | 1 |
| Chen, TS | 1 |
| Lau, OC | 1 |
| McPherson, ZE | 2 |
| Kam, AK | 1 |
| Ruan, C | 1 |
| Francis, KE | 1 |
| Agar, A | 2 |
| Francis, IC | 4 |
| Sim, BW | 1 |
| Barry, P | 5 |
| Williams, SC | 1 |
| Lim, CH | 1 |
| Aulia, FA | 1 |
| Yun, ST | 1 |
| Singh, R | 1 |
| Rahman, N | 1 |
| Murphy, CC | 1 |
| Schimel, AM | 1 |
| Alfonso, EC | 1 |
| Flynn, HW | 1 |
| Faure, C | 1 |
| Perreira, D | 1 |
| Audo, I | 1 |
| Röck, T | 1 |
| Bramkamp, M | 1 |
| Bartz-Schmidt, KU | 1 |
| Mutlu, U | 1 |
| Yörük, E | 1 |
| Röck, D | 1 |
| Thaler, S | 1 |
| Sahu, SK | 1 |
| Dhillon, V | 1 |
| Das, S | 1 |
| Rath, S | 1 |
| Katz, G | 2 |
| Blum, S | 1 |
| Leeva, O | 1 |
| Axer-Siegel, R | 1 |
| Moisseiev, J | 1 |
| Tesler, G | 1 |
| Ehrlich, R | 2 |
| Feutry, F | 1 |
| Simon, N | 1 |
| Genay, S | 1 |
| Lannoy, D | 1 |
| Barthélémy, C | 1 |
| Décaudin, B | 1 |
| Labalette, P | 1 |
| Odou, P | 1 |
| Cheong, KX | 1 |
| Purslow, C | 1 |
| Davey, K | 1 |
| Johnson, M | 1 |
| Pietri, G | 1 |
| Suri, G | 1 |
| Lundström, M | 2 |
| Jabbarvand, M | 1 |
| Hashemian, H | 1 |
| Khodaparast, M | 1 |
| Jouhari, M | 1 |
| Tabatabaei, A | 1 |
| Rezaei, S | 1 |
| Grosso, A | 1 |
| Pertile, G | 1 |
| Marchini, G | 1 |
| Scarpa, G | 1 |
| Ceruti, P | 1 |
| Prigione, G | 1 |
| Romano, MR | 1 |
| Bert, F | 1 |
| Gili, R | 1 |
| Panico, C | 1 |
| Siliquini, R | 1 |
| Engelbert, M | 1 |
| Chow, VS | 1 |
| Creuzot-Garcher, C | 2 |
| Benzenine, E | 1 |
| Mariet, AS | 1 |
| de Lazzer, A | 1 |
| Chiquet, C | 1 |
| Bron, AM | 1 |
| Quantin, C | 1 |
| Giménez-de-la-Linde, M | 1 |
| Giménez-Alcántara, B | 1 |
| Barañano-Alcaide, R | 1 |
| Cordovés-Dorta, L | 1 |
| Abreu-Reyes, JA | 1 |
| Daien, V | 1 |
| Papinaud, L | 1 |
| Gillies, MC | 1 |
| Domerg, C | 1 |
| Nagot, N | 1 |
| Lacombe, S | 1 |
| Daures, JP | 1 |
| Carriere, I | 1 |
| Villain, M | 1 |
| Grzybowski, A | 2 |
| Tang, WW | 1 |
| Oh, LJ | 1 |
| Nguyen, CL | 1 |
| Wang, SS | 1 |
| Mesnard, C | 1 |
| Beral, L | 1 |
| Hage, R | 1 |
| Merle, H | 1 |
| Farès, S | 1 |
| David, T | 1 |
| Pleyer, U | 1 |
| Geldsetzer, K | 1 |
| Díez, MR | 1 |
| De la Rosa, G | 1 |
| Pascual, R | 1 |
| Girón, C | 1 |
| Arteta, M | 1 |
| Gore, DM | 1 |
| Angunawela, RI | 1 |
| Little, BC | 1 |
| Sharifi, E | 1 |
| Porco, TC | 1 |
| Naseri, A | 1 |
| Gardner, S | 1 |
| Seal, D | 1 |
| Gettinby, G | 3 |
| Lees, F | 3 |
| Peterson, M | 3 |
| Revie, C | 1 |
| Roufas, A | 1 |
| Figueira, EC | 1 |
| Pandya, VB | 1 |
| Bhardwaj, G | 1 |
| Chui, J | 1 |
| Rosen, E | 1 |
| Bañuelos, JB | 1 |
| Anijeet, D | 1 |
| Uhart, M | 1 |
| Pirot, F | 1 |
| Boillon, A | 1 |
| Senaux, E | 1 |
| Tall, L | 1 |
| Diouf, E | 1 |
| Burillon, C | 1 |
| Padois, K | 1 |
| Falson, F | 1 |
| Leboucher, G | 1 |
| Pivot, C | 1 |
| Murjaneh, S | 1 |
| Waqar, S | 1 |
| Hale, JE | 1 |
| Kasmiya, M | 1 |
| Jacob, J | 1 |
| Quinn, AG | 1 |
| Cordero-Coma, M | 1 |
| Yilmaz, T | 1 |
| Padula, WV | 1 |
| Rodriguez, E | 1 |
| Lanier, ST | 1 |
| Gualino, V | 1 |
| San, S | 1 |
| Guillot, E | 1 |
| Korobelnik, JF | 2 |
| Colin, J | 1 |
| Trout, H | 1 |
| Massin, P | 1 |
| Gaudric, A | 1 |
| Tadayoni, R | 1 |
| Andrés Alba, Y | 1 |
| Bañuelos Bañuelos, J | 1 |
| Villalobos, PA | 1 |
| Valle, DD | 1 |
| Olavi, P | 1 |
| Cochereau, I | 1 |
| Robert, PY | 2 |
| Hajjar, J | 1 |
| Shahar, J | 1 |
| Zemel, E | 1 |
| Perlman, I | 1 |
| Loewenstein, A | 1 |
| Barreau, G | 1 |
| Mounier, M | 1 |
| Marin, B | 1 |
| Adenis, JP | 1 |
| Winthrop, KL | 1 |
| Herrinton, LJ | 1 |
| van der Merwe, J | 1 |
| Mustak, H | 1 |
| Cook, C | 1 |
| Vazirani, J | 1 |
| Basu, S | 1 |
| Keating, GM | 1 |
| Holak, H | 1 |
| Becker, R | 1 |
| Holak, S | 1 |
| Izdebska, J | 1 |
| Szaflik, JP | 1 |
| Wejde, G | 4 |
| Samolov, B | 1 |
| Seregard, S | 1 |
| Koranyi, G | 2 |
| Montan, PG | 3 |
| Seal, DV | 2 |
| Revie, CW | 2 |
| Wilhelmus, KR | 1 |
| Bohigian, GM | 1 |
| Stenevi, U | 1 |
| Thorburn, W | 1 |
| Filip, M | 1 |
| Dragne, C | 1 |
| Filip, A | 1 |
| Măgureanu, M | 1 |
| Zemba, M | 1 |
| Asandi, R | 1 |
| Spokes, DM | 1 |
| Walters, G | 1 |
| Dinah, C | 1 |
| Sallam, A | 1 |
| Towler, H | 1 |
| Wood, M | 1 |
| Bowman, R | 1 |
| Daya, SM | 1 |
| Bron, A | 1 |
| Guerin, M | 1 |
| Orazakai, A | 1 |
| Cross, KS | 1 |
| Beatty, S | 1 |
| Yu-Wai-Man, P | 1 |
| Morgan, SJ | 1 |
| Hildreth, AJ | 1 |
| Steel, DH | 1 |
| Allen, D | 1 |
| Mollan, SP | 1 |
| Mollan, AJ | 1 |
| Konstantinos, C | 1 |
| Durrani, OM | 1 |
| Butler, L | 1 |
| Kayarkar, VV | 1 |
| Dinakaran, S | 1 |
| Rylander, M | 2 |
| Setterquist, H | 1 |
| Zetterström, C | 1 |
| Jenkins, CD | 1 |
| McDonnell, PJ | 1 |
| Spalton, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intraocular Concentrations Study (Aqueous Humor, Vitreous Humor) of Antibiotics After Local and/or Systemic Administration in Endophthalmitis[NCT03968341] | 5 participants (Actual) | Interventional | 2020-12-09 | Active, not recruiting | |||
| Evaluating the Efficacy, Compliance, and Patient Satisfaction of a New Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population[NCT05157113] | Phase 4 | 70 participants (Anticipated) | Interventional | 2022-05-31 | Recruiting | ||
| Use of Intracameral Moxifloxacin for the Prevention of Acute Endophthalmitis Following Cataract Surgery: a Controlled and Randomized Clinical Trial[NCT02770729] | Phase 3 | 3,640 participants (Actual) | Interventional | 2017-01-31 | Terminated | ||
| The Effects on Betadine 5% Penetration When Using Lidocaine 2% Jelly Versus Topical Tetracaine 0.5% for Topical Phacoemulsification Cataract Surgery.[NCT00827073] | 40 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| Antibiotic Prophylaxis for Cataract Surgery Version 7e January 22 2003[NCT00136344] | 35,000 participants | Interventional | 2003-09-30 | Completed | |||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| Intracameral Levofloxacin (0.5%) Versus Intracameral Cefuroxime (1mg/0.1ml) Effect on Corneal Endothelial Cell Count and Morphology in Uneventful Phacoemulsification[NCT04212078] | Phase 1/Phase 2 | 138 participants (Anticipated) | Interventional | 2019-07-29 | Recruiting | ||
| Cefazolin-Lidocaine Solution for Reducing Pain Associated With Subconjunctival Antibiotic Prophylaxis in Vitreo-Retinal Surgery[NCT02324166] | Phase 4 | 54 participants (Anticipated) | Interventional | 2015-01-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Within 3 hours from time of culture acquisition, the samples will be vortexed for 30 seconds and 100µl aliquots will be plated onto 5% sheep blood and chocolate agar plates. These plates will be incubated with 5% carbon dioxide at 35˚ C for 72 hours. After 72 hours all plates will be read for colony count and identification of all isolates will be performed using routine microbiological methods. The natural log of bacterial bacterial colony count will be used for the outcome measure. (NCT00827073)
Timeframe: (1) Pre-antibiotics swab, and (2) Post-study medication (pre surgery)
| Intervention | Ln(bacterial colony count) (Mean) |
|---|---|
| Tetracaine 0.5% Drop | -0.14 |
| Lidocaine 2% Jelly | -0.52 |
(NCT00827073)
Timeframe: (1) Pre-antibiotics swab and (2) Post-study medication (pre surgery)
| Intervention | bacterial spceies (Mean) | |
|---|---|---|
| pre number of bacterial spices | post surgery number of bacterial speices | |
| Lidocaine 2% Jelly | 1 | 1 |
| Tetracaine 0.5% Drop | 1 | 1 |
7 reviews available for cefuroxime and Endophthalmitis
| Article | Year |
|---|---|
Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2022 |
Effect of cefuroxime intracameral injection antibiotic prophylactic on postoperative endophthalmitis wound post-cataract: A meta-analysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cefuroxime; Endophthalmitis; Humans; Postop | 2023 |
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2018 |
Role of topical, subconjunctival, intracameral, and irrigative antibiotics in cataract surgery.
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefurox | 2013 |
Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2013 |
[Levofloxacin (oftaquix) a fluoroquinolone of a new generation in prevention of the postoperative endophthalmitis following uncomplicated cataract surgery--the study of the European Society of Cataract and Refractive Surgeons (ESCRS)].
Topics: Administration, Topical; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Europe; Humans; Injecti | 2005 |
[Prophylaxis for postcataract endophthalmitis].
Topics: Administration, Oral; Anterior Chamber; Antibiotic Prophylaxis; Asepsis; Cataract Extraction; Cefuro | 2007 |
8 trials available for cefuroxime and Endophthalmitis
| Article | Year |
|---|---|
Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prop | 2020 |
The ESCRS postoperative endophthalmitis prospective trial 15 years later.
Topics: Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; | 2021 |
[Will intracameral cefuroxime become the new standard in endophthalmitis prevention?].
Topics: Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Europe; Eye Infections, Bacterial; Female; Human | 2008 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; | 2007 |
Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery.
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Aqueous Humor; Cefuroxime; Cell Count; Cephalospori | 2002 |
Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery.
Topics: Cataract Extraction; Cefuroxime; Conjunctiva; Conjunctival Diseases; Edema; Endophthalmitis; Eye Hem | 1990 |
82 other studies available for cefuroxime and Endophthalmitis
| Article | Year |
|---|---|
Why do scientific advances take so long to be incorporated into clinical practice? The case of intracameral injection of antibiotics to prevent acute endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; | 2022 |
Commentary: Preventing endophthalmitis after cataract surgery: An update.
Topics: Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infections, B | 2022 |
The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high-volume cataract surgery center.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Brazil; Cataract; Cataract Extracti | 2023 |
Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Bacteria; Cataract Extraction; Cefurox | 2019 |
Commentary: Role of antibiotics in cataract surgery.
Topics: Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; India; Mo | 2020 |
Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Cost-Benef | 2020 |
Safety of intracameral cefuroxime in pars plana vitrectomy.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Cohort Studies; Endophthal | 2021 |
Effect of Intracameral Cefuroxime on Graft Endothelial Cells in Descemet Membrane Endothelial Keratoplasty: A Comparative Study.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Cefuroxime; Cell Count; Corneal En | 2021 |
Endophthalmitis Prophylaxis Failures in Patients Injected With Intracameral Antibiotic During Cataract Surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Cefuroxime; Endophthalmit | 2021 |
Post-traumatic endophthalmitis caused by streptococcus species in preschool children: clinical features, antibiotic susceptibilities and outcomes.
Topics: Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Endophthalmitis; Eye Infections, Bacteri | 2022 |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; C | 2021 |
The ESCRS intracameral cefuroxime study: the debate continues.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2021 |
Incidence of postoperative endophthalmitis with and without use of intracameral moxifloxacin.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infec | 2021 |
Author's reply: Re: Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2017 |
Intracameral cefuroxime in the prevention of postoperative endophthalmitis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2017 |
Endophthalmitis prophylaxis by intracameral antibiotics: In vitro model comparing vancomycin, cefuroxime, and moxifloxacin.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacteria | 2017 |
Bacteriology and cefuroxime resistance in endophthalmitis following cataract surgery before and after the introduction of prophylactic intracameral cefuroxime: a retrospective single-centre study.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cataract Extraction; Cefur | 2019 |
Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azi | 2018 |
Development of Retinal Infarct Due to Intracameral Cefuroxime Injection Following Complicated Cataract Surgery
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye Infec | 2018 |
Incidence of endophthalmitis and impact of prophylaxis with cefuroxime on cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; | 2013 |
Reduction in postoperative endophthalmitis with intracameral cefuroxime.
Topics: Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Disease Outbreaks; Endophthalmitis; England; | 2013 |
Endophthalmitis in Cape Town, South Africa: are the data real?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye | 2013 |
Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Europe | 2014 |
Endophthalmitis in Spain: more than meets the eye?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Eye | 2014 |
Impact of intracameral cefuroxime on the incidence of postoperative endophthalmitis following cataract surgery in Ireland.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2015 |
Endophthalmitis prophylaxis for cataract surgery: are intracameral antibiotics necessary?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2014 |
Retinal toxicity after intracameral use of a standard dose of cefuroxime during cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cefuroxime; Electroretinography; Endophthalmitis; Fluoresce | 2015 |
[Using intracameral cefuroxime reduces postoperative endophthalmitis rate: 5 years experience at the University Eye Hospital Tübingen].
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Causality; Cefuroxime; Com | 2014 |
Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India.
Topics: Adolescent; Adult; Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidim | 2015 |
Intracameral cefuroxime and the incidence of post-cataract endophthalmitis: an Israeli experience.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Bacteria; Cataract Extracti | 2015 |
Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating method.
Topics: Anti-Bacterial Agents; Cefuroxime; Cycloparaffins; Drug Compounding; Drug Packaging; Drug Stability; | 2016 |
Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacteria | 2015 |
Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Budgets; Cataract Extraction; Cefur | 2015 |
Risk factors for endophthalmitis after cataract surgery: Predictors for causative organisms and visual outcomes.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Gr | 2015 |
Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2016 |
Adherence to European Society for Cataract and Refractive Surgery recommendations among Italian cataract surgeons: a survey.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Fem | 2016 |
Re: "Incidence of post-cataract endophthalmitis with intracameral cefuroxime" letter to the editor.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Incidence of post-cataract endophthalmitis with intracameral cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cefuroxime; Endophthalmitis; | 2016 |
Incidence of Acute Postoperative Endophthalmitis after Cataract Surgery: A Nationwide Study in France from 2005 to 2014.
Topics: Acute Disease; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; | 2016 |
Macular oedema after uncomplicated cataract surgery. Possible relationship with the volume of intracameral cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2017 |
Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cef | 2016 |
Has the Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the Time of Cataract Surgery?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; | 2016 |
Has the Time Come for All to Routinely Use Intracameral Antibiotic Prophylaxis at the Time of Cataract Surgery?
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Endophthalmitis after cataract surgery despite intracameral antibiotic prophylaxis with licensed cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefu | 2016 |
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231).
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Endophthal | 2017 |
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231).
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Cefuroxime; Endophthal | 2017 |
[Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience].
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Corynebacterium Infecti | 2009 |
United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections; Guidelin | 2009 |
Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Co | 2009 |
Clinical observations associated with proven and unproven cases in the ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Eye Diseases; Eye Infec | 2009 |
Endophthalmitis following cataract surgery: the sucking corneal wound.
Topics: Anti-Bacterial Agents; Cefuroxime; Cornea; Endophthalmitis; Eye Infections, Bacterial; Humans; Lens | 2009 |
Endophthalmitis.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Cl | 2010 |
Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery Ten-year comparative study.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2010 |
Endophthalmitis after cataract surgery.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacteria | 2010 |
Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis.
Topics: Animals; Antibiotic Prophylaxis; Cefuroxime; Drug Delivery Systems; Endophthalmitis; Humans; Hyaluro | 2010 |
National survey of the use of intraoperative antibiotics for prophylaxis against postoperative endophthalmitis following cataract surgery in the UK.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Hea | 2010 |
Statistical process control charts for ophthalmology.
Topics: Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Data Interpretation, Statistical; Endophthal | 2011 |
[Intracameral cefuroxime injections in prophylaxis of postoperative endophthalmitis after cataract surgery: implementation and results].
Topics: Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Endophthalmitis; Humans; Injections, Intrao | 2010 |
[Endophthalmitis after cataract surgery: epidemiology, clinical features and antibiotic prophylaxis].
Topics: Acute Disease; Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophyla | 2010 |
[The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis].
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Cataract Extr | 2010 |
Ocular toxicity in cataract surgery because of inaccurate preparation and erroneous use of 50mg/ml intracameral cefuroxime.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Color Vision Defects; Corn | 2012 |
[Antibioprophylaxis in ocular surgery: AFSSAPS recommendations].
Topics: Administration, Oral; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extr | 2011 |
[Antibioprophylaxis in ocular surgery. Recommendations].
Topics: Administration, Oral; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime | 2011 |
Physiological and toxicological effects of cefuroxime on the albino rabbit retina.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Disease Models, Animal; Dose-Response Relationship, Drug | 2012 |
Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Ba | 2012 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteria; | 2013 |
Endophthalmitis prophylaxis with intracameral cefuroxime in South Africa.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; En | 2012 |
[Long-term follow-up of bilateral endogenous Klebsiella endophthalmitis].
Topics: Abscess; Aged; Cefotaxime; Cefuroxime; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies | 2003 |
Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study.
Topics: Aged; Antibiotic Prophylaxis; Case-Control Studies; Cataract Extraction; Cefuroxime; Endophthalmitis | 2005 |
ESCRS study of endophthalmitis prophylaxis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime | 2006 |
[The tale of intraocular cefuroxime].
Topics: Anterior Chamber; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Humans; Injections; Postoperat | 2006 |
Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxim | 2007 |
[Toxic anterior segment syndrome].
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Cataract Extraction; Cefuroxime; Endophthalmitis; | 2006 |
Prophylaxis of postoperative endophthalmitis.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract E | 2007 |
Antibiotic name correction.
Topics: Anti-Bacterial Agents; Cataract Extraction; Cefazolin; Cefuroxime; Endophthalmitis; Humans; Incidenc | 2007 |
Prophylactic cefuroxime and endophthalmitis in Tanzania, East Africa.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye In | 2008 |
Endogenous endophthalmitis following ipsilateral carotid endarterectomy.
Topics: Aged; Anti-Bacterial Agents; Blindness; Cefuroxime; Endarterectomy, Carotid; Endophthalmitis; Female | 2008 |
Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery.
Topics: Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Conjunctiva; Endophthal | 2008 |
Incidence of endophthalmitis following vitreoretinal surgery.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Female; Gentamicins; Humans; Mal | 2009 |
Topical anesthesia for phacoemulsification and painless subconjunctival antibiotic injection.
Topics: Aged; Anesthesia, Local; Anesthetics, Local; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Con | 2001 |
Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery.
Topics: Aged; Aged, 80 and over; Anterior Chamber; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; | 2002 |